Searched for
TARO PHARMACEUTICAL INDUSTRIES
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma arm recalls over 17,000 units of antifungal shampoo in US: USFDATaro Pharmaceutical Industries, a Sun Pharma unit, is recalling 17,664 units of Ciclopirox Shampoo in the US. The antifungal medication is ...
- Sun Pharma revises upwards price to fully acquire Taro to USD 43 per shareIn May this year, Sun Pharmaceutical Industries announced a non-binding indication of interest to acquire all of the outstanding ordinary s...
- Sun Pharma offers to acquire 100% stake in Taro in an all-cash dealThe proposed acquisition does not include shares held by Sun Pharma and its affiliates. After the completion of the deal, Sun Pharma will h...
- Sun Pharma's US subsidiary acquires Galderma's companies in US, Japan & CanadaTaro has paid around $99.3 million after taking into account working capital adjustments.
- Sun Pharma hits 4-year low on weak Taro resultsSun Pharma declined 4.99 per cent to Rs 475.4 on BSE. This was the lowest level the stock hit since June 2013.
- Taro appoints Sun Pharma CFO Uday Baldota its CEOBaldota, who has also been nominated to Taro's board of directors, is expected to begin his role as CEO on or about April 1, 2017, and will...
- Taro Pharmaceutical Industries under anti-trust scanner for price hike“We have no additional comments to offer on this matter,” said a Sun Pharma executive to an email query. Sun Pharma's shares on Monday clos...
- Sun Pharma's arm Taro plans shares repurchase worth $250 millionThe board of directors of Taro Pharmaceutical Industries approved a $250 million share repurchase authorisation of its ordinary shares.
- Sun Pharma falls despite earnings being in line with estimatesProfit were in line with estimates despite hopes of a better show after unit Taro Pharmaceutical Industries reported higher earnings earlie...
- Suven inks licensing pact with Taro Pharma for scalp lotionSuven Life Sciences said it has given exclusive license to Taro Pharmaceutical Industries to market its Malathion Lotion.
- Taro postpones shareholders meeting on merger with Sun PharmaIsraeli firm Taro Pharmaceutical Industries Ltd said it postponed a meeting of shareholders to consider the company's proposed merger with ...
- Sun Pharma Q4 net stands at Rs 820 croreSun Pharmaceutical Industries Ltd today reported a consolidated net profit of Rs 820.21 crore for the fourth quarter ended March 31, 2012.
- Sun Pharmaceutical Industries Q1 net at Rs 501 croreSun Pharmaceutical Industries on Thursday reported a consolidated net profit of 501 crore for the first quarter ended June 30, 2011.
- Sun rejects US firm's proposal to buy Taro stakeSun Pharmaceuticals has rejected a proposal from US investor firm Guggenheim to acquire the Indian firm's stake in Israeli drug firm Taro P...
- Sun rejects Guggenheim’s $215 mn offer for Taro stakeGuggenheim Partners offered to buy Sun Pharmaceutical Industries’ stake in Taro Pharmaceuticals Industries on behalf of clients for about $...
- Glenmark enters into licence, supply pact with Taro PharmaPharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...
- Sun launches $7.75/share bid for Taro PharmaSun Pharmaceuticals on Monday launched a cash tender offer for all outstanding ordinary shares of Taro Pharmaceutical Industries for $7.75 ...
Load More
